MEN1 germline mutations have been reported in patients with hereditary and sporadic MEN1, and in FIHP and somatic MEN1 mutations are detected in approximately 20% of sporadic parathyroid tumors (Thakker, 2010). This evidence concerns the gene MEN1 and tumor of parathyroid gland.